Unstable diabetes in a patient receiving anti-TNF-alpha for rheumatoid arthritis

Rheumatology (Oxford). 2007 Jan;46(1):178-9. doi: 10.1093/rheumatology/kel322. Epub 2006 Sep 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Diabetes Mellitus, Type 1 / complications*
  • Etanercept
  • Female
  • Humans
  • Hypoglycemia / chemically induced*
  • Immunoglobulin G / adverse effects
  • Immunologic Factors / adverse effects
  • Middle Aged
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoglobulin G
  • Immunologic Factors
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Adalimumab
  • Etanercept